Literature DB >> 2017649

An office model of outpatient parenteral antibiotic therapy.

A D Tice1.   

Abstract

This office-based program for parenteral therapy began with the im administration of therapy to outpatients in 1981. Since then it has expanded in scope and staff and has provided more than 1,200 courses of i.v. antibiotics. The success of the program is dependent on patients' ability to provide i.v. medication to themselves. These patients are trained and cared for by a team consisting of a physician who specializes in infectious diseases, nurses trained in i.v. techniques, a pharmacist, and microbiologists who are all part of a practice of the subspecialty of infectious diseases. This office model has resulted in excellent quality of care for patients who have experienced few adverse effects or complications. The cost savings of an office program are significant compared to hospitalization for i.v. administration of antibiotics, but issues related to reimbursement are a constant issue.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2017649     DOI: 10.1093/clinids/13.supplement_2.s184

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  6 in total

1.  Community-based parenteral anti-infective therapy (CoPAT). Pharmacokinetic and monitoring issues.

Authors:  D N Williams; J L Raymond
Journal:  Clin Pharmacokinet       Date:  1998-07       Impact factor: 6.447

2.  Home intravenous anti-infective therapy (HIVAT): do the benefits outweigh the risks?

Authors:  D N Williams
Journal:  Drug Saf       Date:  1996-01       Impact factor: 5.606

3.  Home iv antibiotic therapy through a medical day care unit.

Authors:  M Gourdeau; L Deschênes; M Caron; M Desmarais
Journal:  Can J Infect Dis       Date:  1993-05

Review 4.  Use of teicoplanin in community medicine.

Authors:  A P Wilson; R N Grüneberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-09       Impact factor: 3.267

Review 5.  Experience with a physician-directed, clinic-based program for outpatient parenteral antibiotic therapy in the USA.

Authors:  A D Tice
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-07       Impact factor: 3.267

6.  Value and Clinical Impact of an Infectious Disease-Supervised Outpatient Parenteral Antibiotic Therapy Program.

Authors:  Russell M Petrak; Nathan C Skorodin; Robert M Fliegelman; David W Hines; Vishnu V Chundi; Brian P Harting
Journal:  Open Forum Infect Dis       Date:  2016-10-19       Impact factor: 3.835

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.